Ascentage Pharma Group International Balance Sheet (2022-2025) | AAPG

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2022 Dec2023 Dec2024 Jun2025
Assets
Current Assets
Cash & Equivalents 189.20M144.17M124.33M
Cash & Current Investments 189.20M144.17M124.33M
Receivables - Net 20.26M11.57M10.94M
Receivables - Other 0.92M0.85M
Receivables 21.18M12.43M10.83M
Work In Process 0.71M0.38M
Finished Goods 1.54M0.54M
Inventory 2.25M0.92M1.20M
Current Deferred Tax Assets 56.94M42.82M93.45M
Prepaid Assets 12.26M17.15M
Current Assets 186.69M205.23M266.45M
Non-Current Assets
Property, Plant & Equipment (Net) 125.81M118.26M114.64M
Long-Term Investments 2.36M4.55M4.57M
Goodwill 3.43M3.44M3.45M
Intangibles 11.85M11.87M10.58M9.91M
Goodwill & Intangibles 11.85M15.30M14.02M13.23M
Long-Term Deferred Tax 8.38M8.31M6.16M4.66M
Other Non-Current Assets 2.33M3.41M8.26M13.83M
Non-Current Assets 160.58M159.21M158.78M
Assets 347.27M364.44M421.14M
Liabilities
Current Liabilities
Accounts Payables 10.06M12.80M16.57M
Payables 10.06M12.80M16.41M
Accumulated Expenses 0.57M2.07M
Other Accumulated Expenses 28.74M35.93M34.81M
Current Leases 1.36M1.31M
Current Deferred Revenue 5.33M5.22M5.23M
Total Current Liabilities 129.74M162.41M173.00M
Non-Current Liabilities
Non-Current Deffered Revenue 34.89M34.59M
Non-Current Deferred Tax Liability 2.46M2.22M1.68M
Operating Leases 2.42M3.15M4.21M
Other Non-Current Liabilities 2.54M0.87M1.06M
Total Non-Current Liabilities 207.72M163.86M-1.06M
Total Liabilities -57.46M337.46M326.27M
Shareholder's Equity
Common Equity 57.46M9.81M38.17M
Shareholder's Equity 57.46M9.81M38.17M
Liabilities and Shareholders Equity 347.27M364.44M421.14M
Treasury Shares 2.97M0.00M
Retained Earnings -745.15M-803.35M